Question 1

Does Woodline Partners own CTMX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Woodline Partners holds 2,040,210 shares of CTMX (Cytomx Therapeutics), worth $7.7M.

Question 2

How many shares of CTMX does Woodline Partners own?

Accepted Answer

As of its Q2 2026 13F, Woodline Partners holds 2,040,210 shares of CTMX (Cytomx Therapeutics).

Question 3

What is Woodline Partners' CTMX position worth?

Accepted Answer

As of its Q2 2026 13F, Woodline Partners' CTMX position is worth $7.7M.

Question 4

Is Woodline Partners buying or selling CTMX?

Accepted Answer

In Q2 2026, Woodline Partners increased its CTMX position by 39,385 shares (+2.0%).

Question 5

When did Woodline Partners first buy CTMX?

Accepted Answer

Woodline Partners first reported CTMX in its Q3 2024 13F and has listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2M	+2.0%	$7.7M	0.0%	$3.75	28
2026-Q1	Decreased	2M	-14.4%	$9.4M	0.0%	$4.70	0
2025-Q4	Unchanged	2.3M	0.0%	$10M	0.0%	$4.26	0
2025-Q3	Increased	2.3M	0.0%	$7.5M	0.0%	$3.19	27
2025-Q2	Increased	2.3M	+41.0%	$5.3M	0.0%	$2.27	36
2025-Q1	New	1.7M	—	$1.1M	0.0%	$0.64	35
2024-Q4	Exited	0	-100.0%	$0	0.0%	$1.03	0
2024-Q3	New	393,832	—	$464,722	0.0%	$1.18	33